Dr. Nomy Levin-Iaina, MD, is a board-certified specialist in Internal Medicine, Nephrology, and Hypertension, and currently serves as Head of the Nephrology and Hypertension Institute and Head of the Internal Medicine Division at Barzilai University Medical Center, Israel. She received her MD from The Hebrew University of Jerusalem, where her thesis focused on nitric oxide and IGF pathways in diabetic renal hyperfiltration. Dr. Levin-Iaina has extensive clinical, academic, and leadership experience spanning tertiary nephrology care, clinical research, and pharmaceutical medicine. Her research interests include chronic kidney disease (CKD), diabetic kidney disease, hypertension, dialysis outcomes, and real-world implementation of clinical guidelines. She has authored numerous peer-reviewed publications in leading journals and has served as principal investigator in multiple international phase II–III trials. Her most significant recent scientific achievement is an accepted publication in the Journal of the American Society of Nephrology (JASN) addressing underdiagnosis of CKD and its clinical implications, highlighting gaps in detection and opportunities for improved population-level kidney care. Dr. Levin-Iaina is a board member of the Israeli Society of Nephrology and Hypertension, Chair of its CKD and Community Nephrology Forum, an active reviewer for major nephrology journals, and a recipient of competitive research grants.